Clinical Trial Update: Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD [Phase 2, Phase 3]

View source ↗

Summary

A trial update on intravitreal conbercept using modified treat-and-extend regimens for exudative age-related macular degeneration is being studied in Phase 2/Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Exudative Age-related Macular Degeneration

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Exudative Age-Related Macular Degeneration | Phase 2, Phase 3 | Status: UNKNOWN